NCT05141903View on ClinicalTrials.gov

Dietary Supplement With and Without a Probiotic and/or Antibiotic

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

May 23, 2022

Study Completion Date

June 9, 2022

Conditions
Healthy Adults
Interventions
DIETARY_SUPPLEMENT

Antibiotic

Vancomycin (250 mg/dose), Metronidazole (500 mg/dose)

DIETARY_SUPPLEMENT

HMO Concentrate

Concentrated milk fortifiers from donor human milk

DIETARY_SUPPLEMENT

Probiotic

B. infantis

DIETARY_SUPPLEMENT

Food Supplement

Synthetic powder containing 2'-fucosyllactose (2'-FL) and lactoneotetraose (LNnT)

Trial Locations (1)

90630

Altasciences, Cypress

All Listed Sponsors
lead

Prolacta Bioscience

INDUSTRY

NCT05141903 - Dietary Supplement With and Without a Probiotic and/or Antibiotic | Biotech Hunter | Biotech Hunter